Atara Biotherapeutics, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics conference call.
(Operator Instructions)
Please be advised that today's conference call is being recorded. I'd now like to hand the conference over to your host today, Mr. Eric Hyllengren, Vice President, Investor Relations and Finance at Atara Biotherapeutics. Please go ahead.
Thank you, operator. Good morning everyone, and welcome to Atara's strategic collaboration conference call. On today's call, members from the entire executive team will discuss our recently announced strategic collaboration with Bayer, as well as recent data presented at the ASH Annual Meeting on our CAR T, ATA3219 and tab-cel.
We recently issued a joint press release announcing that Atara and Bayer have entered into a strategic collaboration for mesothelin-targeted CAR T cell therapies for solid tumors as well as a press release on new data on our assets presented at ASH. These press
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
